Increasing number of inorganic growth strategies by market key players is expected to drive the growth of global sustained release coating market during the forecast period.
Increasing number of product launches is expected to drive the growth of the global sustained release coating market. For instance, in October 2020, Evonik, a global leader for advanced drug delivery, announced the launch of a new ready-to-use powder premix blend of its EUDRAGIT functional polymers used for oral products with an immediate release profile.
Sustained release coatings are designed to eliminate the need for multiple dosage regimens, particularly for those drugs whose action benefits from achieving reasonably constant blood levels over longer periods. Sustained release coatings are used for the drugs that need to be administered in high doses in the body. Sustained release coating products typically contain higher drug loadings than instant release (IR) products.